News

Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Tuesday, April 22 based on AAII’s Stock Grades.
UC Santa Cruz leaders last week formally recognized the university’s burgeoning relationship with the Universidad Autónoma de Baja California (UABC) through the signing of a memorandum of ...
As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most ...
PIMCO Canada Corp. ("PIMCO Canada”) is pleased to announce today that it has declared monthly distributions on its Class A Units (the "Units”) of the PIMCO Canada closed end funds (the "Funds”). The ...
Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will ...
Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...
Fintel reports that on April 10, 2025, Mizuho initiated coverage of Embecta (NasdaqGS:EMBC) with a Neutral recommendation.
Mizuho initiated coverage of Embecta (EMBC) with a Neutral rating and $15 price target The firm says its rating balances the company’s ...
Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part ...
This potential divestiture follows BD’s 2022 spin-off of its diabetes unit, Embecta, and reflects the company's broader goal to focus capital and management resources on higher-growth areas.
KLP Kapitalforvaltning AS bought a new stake in Embecta Corp. (NASDAQ:EMBC – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...
Vanguard Group Inc. increased its holdings in shares of Embecta Corp. (NASDAQ:EMBC – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent filing with the SEC.